BioStock Studio: CFO about CLS’ aims

Report this content

The reporting season for the fourth quarter of 2022 is coming to an end, and last week medtech company Clinical Laserthermia Systems published its report. The company’s CFO Rolf Bornschein visited BioStock’s studio to summarise Q4 and tell us more about CLS’s aims.

See the interview at biostock.se:

https://www.biostock.se/en/2023/03/cfo-about-cls-aims/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se/en/

Subscribe

Documents & Links

Quick facts

BioStock Studio: CFO about CLS’ aims
Tweet this